Submissions from 2021
Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma., Adi Diab, Scott S Tykodi, Gregory A Daniels, Michele Maio, Brendan D Curti, Karl D Lewis, Sekwon Jang, Ewa Kalinka, Igor Puzanov, Alexander I Spira, Daniel C Cho, Shanhong Guan, Erika Puente, Tuan Nguyen, Ute Hoch, Sue L Currie, Wei Lin, Mary A Tagliaferri, Jonathan Zalevsky, Mario Sznol, and Michael E Hurwitz
Remdesivir and Mortality in Patients with COVID-19., George A Diaz, Alyssa B Christensen, Tobias Pusch, Delaney Goulet, Shu-Ching Chang, Gary L Grunkemeier, Paul A McKelvey, Ari Robicsek, Tom French, Guilford T Parsons, Glenn Doherty, Charles Laurenson, Ryan Roper, Jennifer Hadlock, Cameron J Cover, Brent Footer, Philip Robinson, Mary Micikas, Jennifer E Marfori, Charlotte Cronenweth, Yogavedya Mukkamala, Jamie Mackiewicz, Ekra Rai, Martha Dickinson Matson, Jodie Davila, Justin Rueda, Reda Tipton, Heather Algren, Brittney C Ward, Stephen Malkoski, Tyler Gluckman, Gregory B Tallman, Henry Arguinchona, Terese C Hammond, Steven Standaert, Joshua Christensen, Jose F Echaiz, Robert Choi, Daniel McClung, Albert Pacifico, Martin Fee, Farjad Sarafian, William R Berrington, and Jason D Goldman
Stakeholder Perspectives on Advancing Understanding of Prenatal Opioid Exposure and Brain Development From the iOPEN Consortium of the Healthy Brain and Child Development Study., Jennifer L DiPietro, Kristen L Mackiewicz Seghete, Elizabeth E Krans, Kasey Edwards Snider, Reina Bower, Kea Parker, Janie Gullickson, Alexandra S Potter, Hugh Garavan, Tessa C Vatalaro, Moriah E Thomason, Elinor L Sullivan, and Alice M Graham
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors., Khanh T Do, Laura Quan Man Chow, Karen Reckamp, Rachel E Sanborn, Howard Burris, Francisco Robert, D Ross Camidge, Conor E Steuer, John H Strickler, Amy Weise, Jennifer M Specht, Martin Gutierrez, Peter Haughney, Shawna Hengel, Christina Louise Derleth, and Timothy A Yap
Accuracy of risk models used for public reporting of heart transplant center performance., Stephen J Dolgner, Vidang P. Nguyen, Jennifer Cowger, and Todd F Dardas
Long-term adult congenital heart disease survival after heart transplantation: A restricted mean survival time analysis., Stephen J Dolgner, Vidang P Nguyen, Eric V Krieger, April Stempien-Otero, and Todd F Dardas
Cancer case trends following the onset of the COVID-19 pandemic: A community-based observational study with extended follow-up., Charles W Drescher, Adam J Bograd, Shu-Ching Chang, Roshanthi Weerasinghe, Ann Vita, and Richard Bryan Bell
The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation., Shaan Dudani, Horia Marginean, Joanna Gotfrit, Patricia A Tang, Jose Gerard Monzon, Kristopher Dennis, Hagen F Kennecke, Erin D Powell, Sam Babak, Winson Y Cheung, and Michael M Vickers
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells., Rebekka Duhen, Carmen Ballesteros-Merino, Alexandra K Frye, Eric Tran, Venkatesh Rajamanickam, Shu-Ching Chang, Yoshinobu Koguchi, Carlo Bifulco, Brady Bernard, Rom Leidner, Brendan Curti, Bernard A Fox, Walter Urba, Richard Bryan Bell, and Andrew D Weinberg
Facebook Live: Adult Geriatric Nurse Practitioner Program at University of Providence, Mary Kate Eaton, Cindi Warburton, and Lynette Savage
Older Adult Falls: A coordinated care plan for clinical fall prevention in primary care. Atlanta, GA: National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Elizabeth Eckstrom, Erin M. Parker, Iju Shakya, Robin Lee, and Colleen M Casey (Collaborator)
Facebook Live: COVID-19 Vaccine Myths and Truths, Jessica Ekong, Roberto Patron, and Barry Saver
Interfacility transfer communication of multidrug-resistant organism colonization or infection status: Practices and barriers in the acute-care setting., Katherine D Ellingson, Brie N Noble, Genevieve L Buser, Graham M Snyder, Jessina C McGregor, Clare Rock, Teena Chopra, Lona Mody, and Jon P Furuno
Cryopreserved placental tissue allograft accelerates time to continence following robot-assisted radical prostatectomy., Peter A Elliott, Stephanie Hsiang, Ramkishen Narayanan, James Bierylo, Shu-Ching Chang, Przemyslaw Twardowski, and Timothy G Wilson
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer., Leisha A Emens, Sylvia Adams, Ashley Cimino-Mathews, Mary L Disis, Margaret E Gatti-Mays, Alice Y Ho, Kevin Kalinsky, Heather L McArthur, Elizabeth A Mittendorf, Rita Nanda, David B Page, Hope S Rugo, Krista M Rubin, Hatem Soliman, Patricia A Spears, Sara M Tolaney, and Jennifer K Litton
Enhancing the generation of Eomeshi CD8+ T cells augment the efficacy of OX40- and CTLA-4-targeted immunotherapy., Dana A Emerson, Annah S Rolig, and William L. Redmond
Pearls from a Clinician-Researcher in an Integrated Health care Delivery System., Kate Michi Ettinger, Vivian M Ettinger, Marc G Jaffe, David A Schroeder, and Joan C Lo
383 Durable responses with intratumoral electroporation of plasmid interleukin 12 plus pembrolizumab in patients with advanced melanoma progressing on an anti-PD-1 antibody: updated data from keynote 695, Pablo Fernandez-Penas, Carmen Ballesteros-Merino, Shawn M. Jensen, Bernard A Fox, and See full list of authors in comments
Updated report of a phase II randomized trial of transoral surgical resection followed by low-dose or standard postoperative therapy in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN cancer research group (E3311)., Robert L. Ferris, Yael Flammand, Richard Bryan Bell, and See list of authors in comments
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial., Robert L Ferris, William C Spanos, Rom Leidner, Anthony Gonçalves, Uwe M Martens, Chrisann Kyi, William Sharfman, Christine H Chung, Lot A Devriese, Helene Gauthier, Simon I Chiosea, Lazar Vujanovic, Janis M Taube, Julie E Stein, Jun Li, Bin Li, Tian Chen, Adam Barrows, and Suzanne L Topalian
Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors., Corey C Foster, Marcus Couey, Sara E Kochanny, Arun Khattri, Rajesh K Acharya, Yi-Hung Carol Tan, Ryan J Brisson, Rom S Leidner, and Tanguy Y Seiwert
Evaluating the cancer surfaceome: a possible strategy to identify targets and monitor immunity, Bernard A Fox
Exploiting Autophagy and the Ubiquitin Pathway to Educate the Immune System and Improve Cancer Immunotherapy, Bernard A Fox
Immunogenic cell death and antigen release, Bernard A Fox
Shared Immunogenic Cancer Antigens in Humans and Combination Immunotherapy Clinical Trials that Exploit Those Antigens, Bernard A Fox
Translation: An Iterative and Team Process – Our Path to the Development of Triplet Cancer Immunotherapy, Bernard A Fox
Shaping a Vision for Data Change, Lizzie Fussell and Bentley Moses
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study., Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, Dae Ho Lee, Benjamin Besse, Christina S Baik, Robert C Doebele, Philippe A Cassier, Gilberto Lopes, Daniel S W Tan, Elena Garralda, Luis G Paz-Ares, Byoung Chul Cho, Shirish M Gadgeel, Michael Thomas, Stephen V Liu, Matthew H Taylor, Aaron S Mansfield, Viola W Zhu, Corinne Clifford, Hui Zhang, Michael Palmer, Jennifer Green, Christopher D Turner, and Vivek Subbiah
SGNTGT-001: A phase 1 study of SEA‑TGT, an effector-function enhanced monoclonal antibody (mAb), in advanced malignancies (trial in progress)., Elenda Garralda, Rachel E Sanborn, and See list of authors in comments
Re-entry Housing Collaborative Final Evaluation Report, Monique Gill, Ritu Ghosal, Kyle Jones, and Aisha K Gilmore
The longitudinal relationship between immune cell profiles and frailty in patients with breast cancer receiving chemotherapy., Nikesha Gilmore, Supriya Mohile, Lianlian Lei, Eva Culakova, Mostafa Mohamed, Allison Magnuson, Kah Poh Loh, Ronald Maggiore, Elizabeth Belcher, Alison Conlin, Lora Weiselberg, Mary Ontko, and Michelle Janelsins
Hypertrophic cardiomyopathy: diagnosis and therapeutic options., Ty J Gluckman
Cardiovascular care in unusual places—delivering value beyond bricks and mortar, Tyler J Gluckman
Cardiovascular involvement in COVID-19: The good, the bad, and the unknown, Tyler J Gluckman
Clinical care in a post-pandemic world: what we learned and where we go from here, Tyler J Gluckman
COVID-19’s impact on common cardiovascular quality metrics, Tyler J Gluckman
Evolving treatment approaches for hypertrophic cardiomyopathy, Tyler J Gluckman
How will selected 2021 ACC clinical trial findings change our practice?, Tyler J Gluckman
Optimal LDL-cholesterol: Individualizing treatment using statins and nonstatin therapy, Tyler J Gluckman
Peer-to-peer quality programs that actually work, Tyler J Gluckman
Quality of care, appropriate use criteria, the ACC-NCDR Registry and professional code of ethics, Tyler J Gluckman
Same day discharge- what opportunities exist and why should I be doing it?, Tyler J Gluckman
Same day discharge- what opportunities exist and why should I be doing it?, Tyler J Gluckman
What did we learn from COVID-19?, Tyler J Gluckman
Evolving Treatment Approaches for Hypertrophic Cardiomyopathy: Essential Updates for Specialty Pharmacy, Tyler J Gluckman, Martin S. Maron, Ryan J. Atkinson, Donna M. Chiefari, Judith R. Sands, and Henry A. Solomon
Outreach: Preliminary safety and efficacy results from a phase 2 study of lisocabtagene maraleucel (liso-cel) in the nonuniversity setting., John E Godwin, Bassam I. Mattar, and See list of authors in comments
Outreach: Results from a Phase 2 Study of Lisocabtagene Maraleucel (liso-cel) Administered As Inpatient (Inpt) or Outpatient (Outpt) Treatment in the Nonuniversity Setting in Patients (Pts) with R/R Large B-Cell Lymphoma (LBCL), John E Godwin and See full list of authors in comments
Assessing the risk of thromboembolism in cancer patients receiving immunotherapy., Abhishek Goel, Arjun Khorana, Thomas Kartika, Sonia Gowda, Derrick L Tao, Rajat Thawani, and Joseph J Shatzel
Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature., Jason D Goldman, George Diaz, and Walter Urba
The Dynamics of pre-existing T cells in tumors and the effects of radiation therapy, M Gough
One man, three tick-borne illnesses., Leah Grant, Imran Mohamedy, and Laura Loertscher
Facebook Live: COVID-19, Homeschooling and Teen Mental Health, Roseann Gretchell and Tyson Payne
Weight Stigma: How it harms our patients and what we can do about it, Stephanie Griffith
Moral Distress Among Oncology Social Workers., Ting Guan, Krista Nelson, Shirley Otis-Green, Makeeta Rayton, Tara Schapmire, Lori Wiener, and Brad Zebrack
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer., Andrew J Gunderson, Venkatesh Rajamanickam, Cynthia Bui, Brady Bernard, Joanna Pucilowska, Carmen Ballesteros-Merino, Mark Schmidt, Kayla McCarty, Michaela Philips, Brian D. Piening, Christopher Dubay, Terry R Medler, Phillipa Newell, Paul D Hansen, Eric Tran, Ephraim Tang, Carlo Bifulco, Marka R Crittenden, Michael J. Gough, and Kristina H Young
Population Health Innovations and Payment to Address Social Needs Among Patients and Communities With Diabetes., Kathryn E Gunter, Monica E Peek, Jacob P Tanumihardjo, Evalyn Carbrey, Richard D Crespo, Trista W Johnson, Brenda Rueda-Yamashita, Eric I Schwartz, Catalina Sol, Cody M Wilkinson, J O Wilson, Emily Loehmer, and Marshall H Chin
LB180 - Clinical biomarker studies with two fusion-enhanced versions of oncolytic HSV (RP1 and RP2) alone and in combination with nivolumab in cancer patients indicate potent immune activation, Kevin J. Harrington, Francesca Aroldi, Joseph J. Sacco, Mohammed M. Milhem, Brendan Curti, Ari M. Vanderwalde, Scott Baum, Adel Samson, Anna C. Pavlick, Jason A. Chesney, Jiaxin Niu, Terence D. Rhodes, Tawnya L. Bowles, Robert Conry, Anna Olsson-Brown, Douglas E. Laux, Pablo Nenclares, Lavita Menezes, Alex Deterding, Victoria Roulstone, Joan Kyula, Suzanne Thomas, Praveen K. Bommareddy, Selda Samakoglu, Andrea Pirzkall, Robert S. Coffin, and Mark R. Middleton
The frequency of medical reversals in a cross-sectional analysis of high-impact oncology journals, 2009-2018., Alyson Haslam, Jennifer Gill, Tyler Crain, Diana Herrera-Perez, Emerson Y Chen, Talal Hilal, Myung S Kim, and Vinay Prasad
The frequency of assessment of progression in randomized oncology clinical trials., Alyson Haslam, Jennifer Gill, and Vinay Prasad
Facebook Live: Social Isolation and how it affects mental health, Robin Henderson and Brette Borow
Clinical Outcomes Associated With Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock., Jaime Hernandez-Montfort, Shashank S Sinha, Katherine L Thayer, Evan H Whitehead, Mohit Pahuja, Arthur Reshad Garan, Claudius Mahr, Jillian L Haywood, Neil M Harwani, August Schaeffer, Detlef Wencker, Manreet Kanwar, Esther Vorovich, Jacob Abraham, Daniel Burkhoff, and Navin K Kapur
The great disconnect: challenges of getting users to full text, A Hickner, E Phetteplace, L Barnett, A Spencer, and Basia Delawska-Elliott
First report of the safety/tolerability and preliminary antitumor activity of HB-201 and HB-202, an arenavirus-based cancer immunotherapy, in patients with HPV16+ cancers., Alan L. Ho, Marshall R. Posner, and Rom Leidner
Age-friendly health systems: Creating meaningful change in outpatient primary care, MO Hodges and Colleen Casey
Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid Tumors., David S Hong, Olivier Rixe, Vi K Chiu, Patrick M Forde, Tomislav Dragovich, Yanyan Lou, Asha Nayak-Kapoor, Rom Leidner, James N Atkins, Agron Collaku, Floyd E Fox, Margaret A Marshall, and Anthony J Olszanski
Healthcare utilization and cost outcomes for a multicenter first seizure and new onset epilepsy clinic., Emily R Hudson, Alexandra Lesko, Lindsay Lucas, Elizabeth Baraban, and Evan J Fertig
Right Ventricular Dysfunction Is Common and Identifies Patients at Risk of Dying in Cardiogenic Shock., Pankaj Jain, Katherine L Thayer, Jacob Abraham, Kay D Everett, Mohit Pahuja, Evan H Whitehead, Benjamin P Schwartz, Anuradha Lala, Shashank S Sinha, Manreet K Kanwar, A Reshad Garan, Jaime A Hernandez-Monfort, Claudius Mahr, Esther Vorovich, Detlef Wencker, James M McCabe, Tara Jones, Maithri Goud, Paulina Baca, Neil Harwani, Daniel Burkhoff, and Navin K Kapur
Initial results of a first-in-human, dose escalation study of a cell-based vaccine in HLA A*02+ patients (pts) with recurrent, locally advanced or metastatic HPV16+ solid tumors: SQZ-PBMC-HPV-101., Antonio Jimeno, Joaquina C. Baranda, Matthew H Taylor, and See all authors in comments
Continuous Monitoring of Risk-Adjusted Outcomes: Excess Deaths vs. Lives Saved., Ruyun Jin, Gary L Grunkemeier, and Anthony P Furnary
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies., Melissa Johnson, Anthony El-Khoueiry, Navid Hafez, Nehal Lakhani, Hirva Mamdani, Jordi Rodon, Rachel E Sanborn, Javier Garcia-Corbacho, Valentina Boni, Mark Stroh, Alison L Hannah, Song Wang, Henry Castro, and Alexander Spira
Comparable Outcomes for Transcarotid and Transfemoral Transcatheter Aortic Valve Replacement at a High Volume US Center., Brandon Jones, V Kumar, Shih-Ting Chiu, Ethan C Korngold, Robert W. Hodson, Kateri Spinelli, and Eric B Kirker
Health and Health Care Use Strongly Associated with Cumulative Burden of Social Determinants of Health, Kyle G Jones, Sarah E Roth, and Keri B Vartanian
Health and Health Care Use Strongly Associated with Cumulative Burden of Social Determinants of Health., Kyle G Jones, Sarah E Roth, and Keri B Vartanian
Rapid, successful adoption of virtual outpatient cardiology care during the COVID-19 pandemic, Lesley Jones Larson, D Christensen, S Long, Lian Wang, Kateri Spinelli, and Xiaoyan Huang
Do small baby units improve extremely premature infant outcomes?, Joseph W Kaempf and Kanekal Gautham
Impact of Age on Outcomes in Patients With Cardiogenic Shock., Manreet Kanwar, Katherine L Thayer, Arthur Reshad Garan, Jaime Hernandez-Montfort, Evan Whitehead, Claudius Mahr, Shashank S Sinha, Esther Vorovich, Neil M Harwani, Elric Zweck, Jacob Abraham, Daniel Burkhoff, and Navin K Kapur
Impact of age on outcomes in patients with cardiogenic shock, M Kanwar, KL Thayer, A Garan, J Hernandez-Montfort, EH Whitehead, C Mahr, S Sinha, E Vorovich, NM Harwani, E Zweck, Jacob Abraham, and D Burkhoff
Multi-omic Profiling of Simultaneous Ductal Carcinoma In Situ and Invasive Breast Cancer, Henry G. Kaplan, Anna B. Berry, Alexa Dowdell, and Brian D. Piening
Treatment of PCM1-JAK2 fusion tyrosine kinase gene-related acute lymphoblastic leukemia with stem cell transplantation, Henry G Kaplan, Carlo Bifulco, Ruyun Jin, James M Scanlan, and David Colvin
Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination., Ludwig Kappos, Stanley Cohan, Douglas L Arnold, Randy R Robinson, Joan Holman, Sami Fam, Becky Parks, Shan Xiao, and Wanda Castro-Borrero
Facebook Live: Her Heart Health: Spotlight on Women's Heart Program, Laurie Kelly and Lori Tam
Treatment dependent improvements in survival of stage 2/3 rectal cancer patients treated with trimodality therapy between 2006-2016, an NCDB analysis., Hagen F Kennecke, Henry T. Bahnson, and See list of authors in comments
CCTG CO.28 primary endpoint analysis: Neoadjuvant chemotherapy, excision and observation for early rectal cancer, the NEO trial., Hagen F Kennecke, Carl J. Brown, and See full list of authors in comments
Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection., Yeraz Khachatoorian, Vahe Khachadourian, Eleanor Chang, Erick R Sernas, Elaine F Reed, Mario Deng, Brian D. Piening, Alexandre C Pereira, Brendan Keating, and Martin Cadeiras
"Custom" Plate in a Day-Accurate Predictive Hole Fabrication Using Point-of-Care 3-Dimensional Printing., Baber Khatib, Marcus Couey, Ashish Patel, Allen C Cheng, and Richard Bryan Bell
Updates in Management of Craniomaxillofacial Gunshot Wounds and Reconstruction of the Mandible., Baber Khatib, Savannah Gelesko, Melissa Amundson, Allen Cheng, Ashish Patel, Tuan Bui, Eric J Dierks, and R Bryan Bell
A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy., Isaac Kim, Venkatesh Rajamanickam, Brady Bernard, Brie Chun, Yaping Wu, Maritza Martel, Zhaoyu Sun, William L Redmond, Katherine Sanchez, Reva Basho, Heather McArthur, and David B Page
The Benefits of Transcarotid Access for Transcatheter Aortic Valve Replacement: When will we stop being so surprised?, Eric B Kirker and Brandon Jones
Hospital Procedure Volume Not Associated with 30-day Stroke Rate for Transcarotid or Transaxillary/Subclavian TAVR., Eric Kirker and Brandon Jones
Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab., Yoshinobu Koguchi, Noriko Iwamoto, Takashi Shimada, Shu-Ching Chang, John Cha, Brendan Curti, Walter Urba, Brian D. Piening, and William L. Redmond
Alternative access: Transcarotid, Ethan C Korngold
Changes in Carcinoid Syndrome Symptoms Among Patients Receiving Telotristat Ethyl in US Clinical Practice: Findings from the TELEPRO-II Real-World Study., Matthew H Kulke, Hagen F Kennecke, Kris Murali, and Vijay N Joish
Unaltered IL-2 encapsulated in acoustically active lipid microspheres for systemic but targeted microdose delivery to tumor microenvironment., Clayton Larsen, Llew Keltner, William L. Redmond, and Rhodemann Li
Cardiovascular risk assessment and disease management in patients with cancer, Michael Layoun
Chapter: Cardiovascular complications, Michael Layoun and M Ferencik
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study., Chung-Han Lee, Amishi Yogesh Shah, Drew Rasco, Arpit Rao, Matthew H Taylor, Christopher Di Simone, James J Hsieh, Alvaro Pinto, David R Shaffer, Regina Girones Sarrio, Allen Lee Cohn, Nicholas J Vogelzang, Mehmet Asim Bilen, Sara Gunnestad Ribe, Musaberk Goksel, Øyvind Krohn Tennøe, Donald Richards, Randy F Sweis, Jay Courtright, Daniel Heinrich, Sharad Jain, Jane Wu, Emmett V Schmidt, Rodolfo F Perini, Peter Kubiak, Chinyere E Okpara, Alan D Smith, and Robert J Motzer
Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma., Rom Leidner, Marka Crittenden, Kristina Young, Hong Xiao, Yaping Wu, Marcus A Couey, Ashish A Patel, Allen C Cheng, Amber L Watters, Carlo Bifulco, George Morris, Lessli Rushforth, Shorin Nemeth, Walter J Urba, Michael Gough, and R Bryan Bell
Cancer microenvironment and genomics: evolution in process., Stanley P Leong, Isaac P Witz, Orit Sagi-Assif, Sivan Izraely, Jonathan Sleeman, Brian Piening, Bernard A Fox, Carlo B Bifulco, Rachel Martini, Lisa Newman, Melissa Davis, Lauren M Sanders, David Haussler, Olena M Vaske, and Marlys Witte
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates., John B Liao, William R Gwin, Renata R Urban, Katie M Hitchcock-Bernhardt, Andrew L Coveler, Doreen M Higgins, Jennifer S Childs, Hania N Shakalia, Ron E Swensen, Sasha E Stanton, Anna V Tinker, Tanya A Wahl, Richard G Ancheta, Kathryn F McGonigle, James Y Dai, Mary L Disis, and Barbara A Goff
